a box of Janssen by Johnson & Johnson On Monday, April 12, 2021, COVID-19 vaccine dosages are shown at Grubb’s Pharmacy on Capitol Hill. Getty Images | Tom Williams | CQ-Roll Call, Inc. According to The Washington Post, which cited four unidentified individuals, the Food and Drug Administration is poised to issue a new warning for Johnson & Johnson’s Covid-19 vaccination, stating that the shot has been associated to a serious but rare autoimmune condition. The Centers for Disease Control and Prevention said in a statement to NBC News that after 12.8 million doses of the J&J vaccine were provided, about 100 preliminary reports of Guillain-Barre syndrome were discovered. Guillain-Barre syndrome is a rare neurological condition in which the immune system assaults a section of the nervous system by mistake. According to the National Institute of Neurological Disorders and Stroke, one out of every 100,000 people is affected each year, and the majority of people recover. According to the CDC, the majority of instances recorded after having the J&J injection occurred two weeks after vaccination and were predominantly in males, many of whom were 50 years or older. According to the agency, there is no evidence of a comparable pattern with Pfizer’s or Moderna’s vaccines. According to the Washington Post, which cited people familiar with the matter, US regulators are anticipated to underline that the J&J vaccine is safe and that its advantages significantly outweigh the potential risks. The FDA and J&J did not respond to CNBC’s request for comment right away. “GBS reports following receipt of the J&J/Janssen COVID-19 Vaccine adverse event reports in the Vaccine Adverse Event Reporting System (VAERS) are uncommon, although they do suggest a tiny risk of this side effect following this vaccine “In a statement to NBC News, the CDC added. The expected new warning is the latest setback for J&J, which has been plagued by vaccine production issues as well as public fears over a rare, possibly fatal blood clotting disease connected to its doses. The vaccine was hailed as a boon after it was approved in late February since it could be maintained at refrigerator temperatures for months and only required one shot, unlike Pfizer’s and Moderna’s, which required more intricate transportation techniques and required two doses. According to data gathered by the CDC, more than 12 million J&J vaccinations have been delivered in the United States. The complete story can be seen here in the Washington Post./n
Read More
